DCR

mUC - M - PDL1 positive metastatic/advanced UC (mUC) - maintenance (M) mUC - M - PDL1 positive

versus BSC
avelumab alone vs. BSC 1 2.03 [1.31; 3.16], 1 RCT, I2=0%
unassessable degree of certainty